- Home
- BLTE vs VICR Comparison
BLTE vs VICR Comparison
Compare BLTE & VICR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- VICR
- Stock Information
- Founded
- BLTE 2018
- VICR 1981
- Country
- BLTE United States
- VICR United States
- Employees
- BLTE N/A
- VICR N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- VICR Industrial Machinery/Components
- Sector
- BLTE Health Care
- VICR Technology
- Exchange
- BLTE Nasdaq
- VICR Nasdaq
- Market Cap
- BLTE 2.1B
- VICR 2.6B
- IPO Year
- BLTE 2022
- VICR N/A
- Fundamental
- Price
- BLTE $64.12
- VICR $49.17
- Analyst Decision
- BLTE Strong Buy
- VICR Hold
- Analyst Count
- BLTE 4
- VICR 2
- Target Price
- BLTE $89.00
- VICR $43.00
- AVG Volume (30 Days)
- BLTE 62.6K
- VICR 232.1K
- Earning Date
- BLTE 11-12-2024
- VICR 10-22-2024
- Dividend Yield
- BLTE N/A
- VICR N/A
- EPS Growth
- BLTE N/A
- VICR N/A
- EPS
- BLTE N/A
- VICR 0.10
- Revenue
- BLTE N/A
- VICR $355,544,000.00
- Revenue This Year
- BLTE N/A
- VICR N/A
- Revenue Next Year
- BLTE N/A
- VICR $10.70
- P/E Ratio
- BLTE N/A
- VICR $487.63
- Revenue Growth
- BLTE N/A
- VICR N/A
- 52 Week Low
- BLTE $31.01
- VICR $30.90
- 52 Week High
- BLTE $86.53
- VICR $61.05
- Technical
- Relative Strength Index (RSI)
- BLTE 44.50
- VICR 40.24
- Support Level
- BLTE $60.00
- VICR $52.66
- Resistance Level
- BLTE $76.87
- VICR $57.55
- Average True Range (ATR)
- BLTE 4.51
- VICR 2.79
- MACD
- BLTE -0.44
- VICR -1.03
- Stochastic Oscillator
- BLTE 24.42
- VICR 7.55
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, advanced power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. Geographically, it derives a maximum of its revenue from the Asia Pacific.